What are the limitations of the palliative performance scale ppsv2?

While the palliative performance scale ppsv2 is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the palliative performance scale ppsv2 to ensure safe bedside use and optimal diagnostic accuracy.

How does the palliative performance scale ppsv2 compare to other PalliativeCare scores?

The palliative performance scale ppsv2 is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the palliative performance scale ppsv2 free to use?

Yes. OpiCalc provides the palliative performance scale ppsv2 completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

Palliative Performance Scale (PPSv2)

PPSv2 is the gold-standard functional assessment tool in specialist palliative care.

PPS (0–100%)

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessment of functional status in patients with life-limiting illness

Determination of hospice eligibility and advance care planning

Prognostic guidance in palliative care populations

Monitoring functional decline over time

Clinical Context

PPSv2 is the gold-standard functional assessment tool in specialist palliative care, replacing Karnofsky in this population.

Section 2

Formula & Logic

Scale Structure

11-stage scale ranging from 0% (dead) to 100% (fully active, normal function). Integrates ambulatory status, activity level, self-care ability, and intake.

Scoring Levels

100%	Fully active, normal function
90%	Restricted in strenuous activities
80%	Normal work/activities with some effort
70%	Self-care; unable to work
60%	Requires occasional assistance; mostly independent
50%	Requires considerable assistance; considerable time in bed
40%	Mostly in bed/chair; requires significant care
30%	Completely bedbound; requires all care
20%	Unresponsive; minimal function
10%	Actively dying
0%	Dead

Section 3

Pearls/Pitfalls

Key Advantages

Palliative-specific; superior to generic performance scales in this population

Simple, rapid assessment requiring no special equipment

Incorporates intake and self-care as key discriminators

Strong prognostic correlation with survival prediction

Known Limitations

Subjective assessment; inter-rater variability possible

Does not capture symptom burden or pain

Limited granularity at extreme scores

Section 4

Next Steps

Prognostic Correlation

PPS ≥ 50%	Survival typically ≥ 4 weeks
PPS 30–40%	Median survival ≈ 2 weeks
PPS < 20%	Median survival ≈ 1 week

Last Comprehensive Review: 2026

Related Palliative Care Tools

Palliative Prognostic Index

Palliative Prognostic

e-PaP Score

Menten Score

Edmonton Symptom Assessment System

IPOS

Distress Thermometer

Memorial Symptom Assessment Scale

Morphine Equivalent Daily Dose

Opioid Risk Tool

Have feedback about this calculator?Let us know.